Mymetics Corp MYMX:OTCQB

RT Quote | Exchange | USD
Last | 04/16/21 EDT
0.093UNCH (UNCH)
52 week range
0.02 - 0.19

...

Loading . . .
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.093
  • 52 Week High0.19
  • 52 Week High Date02/11/21
  • 52 Week Low0.02
  • 52 Week Low Date05/08/20

Key Stats

  • Market Cap28.25M
  • Shares Out303.76M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta0.09
  • YTD % Change17.72

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.093
  • 52 Week High0.19
  • 52 Week High Date02/11/21
  • 52 Week Low0.02
  • 52 Week Low Date05/08/20
  • Market Cap28.25M
  • Shares Out303.76M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta0.09
  • YTD % Change17.72

RATIOS/PROFITABILITY

  • EPS (TTM)-0.02
  • P/E (TTM)-5.56
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-1.932M
  • ROE (MRQ)-
  • Revenue (MRQ)800,000.00
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-622.46%
  • Debt To Equity (MRQ)-114.26%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest From Mymetics Corp

There is no recent news for this security.

Latest From Our Partners

There is no recent news for this security.

Profile

MORE
Mymetics Corporation is a vaccine company. The Company is focused on developing vaccines for infectious diseases. The Company has over five vaccine candidates in its pipeline: human immunodeficiency virus type 1 (HIV-1)/acquired immune deficiency syndrome (AIDS), intra nasal Influenza, Malaria, Herpes Simplex Virus (HSV) and the Respiratory Syncitial Virus (RSV) vaccine. Its technology utilizes virosomes, lipid-based carriers containing functional fusion viral proteins and...
Ronald Kempers
President
Address
European Executive Ofc
route de la Corniche 4
Epalinges
1066
Switzerland